NCT07519421 Different Laser Frequencies on Neuropathic Outcomes in Patients With Bell's Palsy
| NCT ID | NCT07519421 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kafrelsheikh University |
| Condition | Neuropathy, Facial |
| Study Type | INTERVENTIONAL |
| Enrollment | 80 participants |
| Start Date | 2025-12-01 |
| Primary Completion | 2026-05-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 80 participants in total. It began in 2025-12-01 with a primary completion date of 2026-05-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
this study was done to compare different laser frequencies on neuropathic outcomes in patients with Bell's palsy.
Eligibility Criteria
Inclusion Criteria: 1. Eighty subjects from both genders diagnosed with Bell's palsy will be recruited through direct referrals from their independent physician's neurology department. 2. Subjects aged 18 and above from all genders 3. Unilateral Bell's palsy either on the right or left side. 4. The Facial disability index will be used for assessment and progression of Bell's palsy before and after treatment protocol. 5. Patients will on level II, III, IV and V of House-Brackmann scale. Exclusion Criteria: 1. We will exclude patients who had central nervous system pathology, sensory loss over the face, or recurrence of facial palsy. 2. Upper motor neuron fascial nerve palsy. 3. Any infant or child (\<18 years). 4. Bilateral Facial nerve palsy 5. Severe hypertension (Blood pressure more than 200/120 mmHg).
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07519421 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Neuropathy, Facial. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07519421 currently recruiting?
Yes, NCT07519421 is actively recruiting participants. Contact the research team at pt.ahmad3@gmail.com for enrollment information.
Where is the NCT07519421 trial being conducted?
This trial is being conducted at Madinah, Saudi Arabia.
Who is sponsoring the NCT07519421 clinical trial?
NCT07519421 is sponsored by Kafrelsheikh University. The trial plans to enroll 80 participants.